Clinical Trials Browser

Glioma × vorasidenib × 90 days × Clear all

NCT07629089 2026-06-05

VALIENT

Phase 1 Not yet recruiting

Brain Neoplasms, Glioma

NCT07547163 2026-04-23

LGG PRO's

Glioma